FindMyKOL
Clinical trialNCT00488605WithdrawnPhase 3Interventional

H-9926-LCH III: Treatment Protocol of the Third International Study for Langerhans Cell Histiocytosis

SponsorUniversity of New MexicoEnrollment0Leukemia
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

LCH III is an international, multicentric, prospective clinical study comprised of: * a randomized clinical trial for multisystem "RISK" patients and * a randomized clinical trial for multisystem "LOW RISK" patients and * a pilot study for patients with single system MFB and localized "SPECIAL SITES"

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of New Mexico

    Albuquerque, New Mexico, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Aug 2023
Primary completion
1 Aug 2023
Completion
1 Aug 2023
Last update posted
3 Aug 2023
Registered enrollment
0
Registry id
NCT00488605

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.